BKYI — Stock Film
STOCK FILMSCENE 1/11BKYI · $2.65
Stock Expert AI presents
BKYI
BIO-key International, Inc
~5 min film100% real numbersplain English
WHAT DOES THIS COMPANY DO?
BIO-key International, Inc. What it actually does.

Develops and markets fingerprint identification biometric technology. Provides enterprise-ready identity access management (IAM) software solutions. Now — the numbers.

on the stock market since 1997
42 employees
$2.9M market value
WHERE DOES THE MONEY COME FROM?
58%License
LicenseHardware 23%Services 20%
58% of all revenue comes from a single line: License.

That much dependence is a risk in itself: if this one line weakens, the whole company feels it directly.

Revenue last year:
$6.1M
The loss that same year:
$4.6M
For every $1 it earns, the company spends $1.8.

The company is still in the product-building phase: its spending runs far above its sales. That only changes once the product starts selling at scale.

In the vault right now:
$2.7M
DEBT: $704K
At this pace, that money lasts less than a year.

Before the clock runs out, either sales must climb sharply or new money must come in. This is the most critical line in the whole picture.

INSIDE THE REPORT CARD

We compared this company with its own sector across five subjects.

A score of 50 means class average.

BUSINESS QUALITY
13
very weak

Clearly below the class average.

FINANCIAL STRENGTH
24
very weak

Clearly below the class average.

VALUATION
51
average

The price isn’t cheap next to earnings — that’s why this grade sits in the middle.

GROWTH
6
very weak

Clearly below the class average.

PRICE MOMENTUM
15
very weak

Clearly below the class average.

WORTH WATCHING

Growth: Sales growth trails the sector average.

Business Quality: Profit power and business quality trail similar companies in the sector.

THE COUNCIL REVIEW
9

angles, checked one by one.

The 4 that stand out are on screen; the rest came back neutral.

The council scores out of 10; report-card grades are out of 100.

STRENGTHS
Heavy investment in the future10/10
WEAK SPOTS
The stock has lost its spark3/10
Costs eat into the margin4/10
Thin trading in the shares4/10
WORTH WATCHING

Cost Efficiency: As sales grow, profit fails to keep the same pace.

THE FIVE-YEAR JOURNEY
A long and steep decline.

An investor who bought at the very peak is down 100% today. The business is the same; what changed most is the price — and the expectations — the market pins on it.

1
THE BRIGHT SIDE · 1/2
The product is selling

Sales run at $6.1M a year. A small number, but proof the product has real buyers.

2
THE BRIGHT SIDE · 2/2
Executives are buying their own stock

Over the last 12 months, company executives reported 30 buys and 0 sells. Management buying with its own money is usually read as a good sign.

1
THE RISKS · 1/2
Small sales, big loss

A loss of $4.6M against $6.1M in annual sales. And on top of that, sales fell from the year before.

2
THE RISKS · 2/2
The cash has a countdown

At the current pace of spending, the cash lasts less than a year. After that, the company needs to find new money.

FINALE · THE GRADE
F
20 / 100 · MoonshotScore

On our five-subject report card, BKYI sits behind the class. A low grade doesn’t mean “doomed” — it means “big claim, small proof.”

The takeaway: BKYI is a high-risk stock — not yet profitable, and its future rides on its product catching on.

What would you like to do next?
Open the stock page →
This was a film — not investment advice.
Data: FMP & company filings
Sep 11, 2026 · stockexpertai.com · Stock Film